Valuation: Aprogen Medicines Inc.

Market Cap 46.09B 34.28M 30.61M 28.56M 25.94M 48.82M 3.32B 49.29M 343M 134M 1.69B 129M 126M 5.43B P/E 2024
-3.44x
P/E 2025 -2.95x
Enterprise Value 183B 136M 122M 114M 103M 194M 13.2B 196M 1.36B 533M 6.71B 512M 501M 21.57B EV / Sales 2024
1.93x
EV / Sales 2025 2.99x
Free-Float
81.19%
Yield 2024 *
-
Yield 2025 -
09-23 Aprogen Biologics Inc. announced that it has received KRW 20.0000011 billion in funding from Aprogen Medicines Inc. CI
09-23 Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
09-21 Aprogen Medicines Inc.(KOSE:A007460) dropped from S&P Global BMI Index CI
09-03 Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
09-03 Aprogen Biologics Inc. announced that it expects to receive KRW 20.0000011 billion in funding from Aprogen Medicines Inc. CI
08-21 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding from Jade New Technology Association CI
08-14 Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-10 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding from Jade New Technology Association CI
07-27 Aprogen Biologics Inc. announced that it has received KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
07-23 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding CI
07-14 Aprogen Medicines to Raise 2 Billion Won Through Convertible Bond Issue MT
07-14 Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
07-13 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding CI
1 day-3.94%
1 week+7.74%
Current month+7.74%
1 month-2.12%
3 months-14.08%
6 months-50.60%
Current year-80.15%
1 week 1,976
Extreme 1976
2,335
1 month 1,875
Extreme 1875
2,335
Current year 1,875
Extreme 1875
11,880
1 year 1,875
Extreme 1875
14,070
3 years 1,875
Extreme 1875
28,410
5 years 1,875
Extreme 1875
94,950
10 years 1,875
Extreme 1875
875,250
Manager TitleAgeSince
Chief Executive Officer 63 27/12/2017
Comptroller/Controller/Auditor 69 28/03/2018
Director TitleAgeSince
Director/Board Member 63 29/11/2022
Director/Board Member 64 18/07/2022
Director/Board Member 62 13/10/2023
Date Insider Type Main position Quantity % Market Cap. Importance
1/17/25 A Others 7,673 0.0025% -
1/19/24 A Free 101,429 0.0383%
1/19/24 A Free 198,187 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
-3.94%+7.74%-78.52%-89.40% 35.81M
-0.61%-0.89%+26.15%+141.74% 120B
-0.48%-0.29%+21.00%+39.17% 96.56B
-1.77%+2.92%+120.30%+185.88% 64.93B
+0.41%+1.84%+32.32%+77.11% 59.51B
+1.32%+1.94%+6.41%+79.94% 57.18B
-2.35%+1.28%+33.76%+53.55% 36.37B
+0.98%+3.85%-4.12%+22.99% 29.97B
-2.66%-0.85%+35.85%+74.01% 30.6B
-2.82%-0.47%+38.49%+6.61% 29.36B
Average -1.19%+2.61%+23.16%+59.16% 52.47B
Weighted average by Cap. -0.68%+2.06%+35.45%+89.84%

Financials

2024 2025
Net sales 150B 112M 99.71M 93.02M 84.5M 159M 10.81B 161M 1.12B 437M 5.5B 419M 410M 17.67B 118B 87.75M 78.36M 73.1M 66.41M 125M 8.5B 126M 878M 343M 4.32B 329M 322M 13.89B
Net income -58.08B -43.2M -38.58M -35.99M -32.69M -61.52M -4.18B -62.12M -432M -169M -2.13B -162M -159M -6.84B -70.2B -52.22M -46.63M -43.5M -39.52M -74.36M -5.06B -75.09M -522M -204M -2.57B -196M -192M -8.27B
Net Debt 70.04B 52.1M 46.52M 43.4M 39.43M 74.19M 5.05B 74.91M 521M 204M 2.56B 196M 191M 8.25B 137B 102M 91.07M 84.96M 77.17M 145M 9.88B 147M 1.02B 399M 5.02B 383M 375M 16.14B
Projected Income Statement - Annual - Aprogen Medicines Inc.
Logo Aprogen Medicines Inc.
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Employees
160
Date Price Change Volume
08/10/26 ₩2,075.00 -3.94% 167,157
07/10/26 ₩2,160.00 -0.69% 617,191
06/10/26 ₩2,175.00 +1.64% 160,008
02/10/26 ₩2,140.00 +8.30% 362,977
01/10/26 ₩1,976.00 +2.60% 125,489
  1. Stock Market
  2. Stocks
  3. A007460 Stock